Global News

[ad_1] There's a global investing opportunity in a corner of health care that is both "significant and underappreciated," according to Barclays. The segment is clinical nutrition, which the bank defined as an area focused on patients who need specific supplemental nutrition because of chronic health care conditions or because they are unable to eat. Barclays pointed to several growth drivers: "Rising chronic conditions, ageing populations and continued pressure on healthcare spending should continue to support the growth of this industry." "Clinical nutrition provides supplemental nutrition for those who are malnourished and is a significant and underappreciated opportunity worth c.$19bn today, driven by strong underlying themes such as ageing population, malnutrition and an increasing focus on self-care," the bank said in an April 12 note. It expects the market will grow to $28 billion by 2030, with China's share of the market rising from 20%

[ad_1] Food-delivery company Wonder Group has gotten a cash infusion from Nestle , as the startup looks to sell high-tech kitchen equipment and prepared ingredients to businesses such as hotels, hospitals and sports arenas. The deal includes a $100 million investment from Nestle, along with a strategic partnership, according to sources familiar with the matter who asked not to be named because financial terms of the deal are not public. Nestle and Wonder confirmed the deal but declined to reveal transaction details. The funding could get Wonder a step closer to its ambitions of making it easier, faster and cheaper for busy families to have high-quality meals at home. The startup, which was valued at about $3.5 billion when it closed a $350 million funding round in June, was founded in 2018 by serial entrepreneur and former Walmart e-commerce chief Marc Lore. Wonder recently struck a deal to acquire meal-kit company Blue Apron for $103 million. It has also developed kitchen equ